Skip to main content
Clinical Trials/CTRI/2025/11/097336
CTRI/2025/11/097336RecruitingPhase 2

Effect of Blood flow restriction therapy on muscle fatigue and performance in recreational runners

Not provided1 site in 1 country46 target enrollmentStarted: November 25, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
46
Locations
1
Primary Endpoint
Running performance (distance measured)

Study Overview

Brief Summary

The present study aims to determine the effect of Blood Flow Restriction (BFR) training on muscle fatigue and physical performance in recreational runners. Participants will undergo a 6-week training program, where one group performs low-load resistance exercises under BFR and the other follows a standard exercise protocol without restriction. The outcomes will be assessed through parameters such as running performance (12-minute Cooper test), muscle fatigue (lactate levels), leg strength (1-RM test), lower limb endurance (single-leg sit-to-stand test), and circumference measurements. The study seeks to identify whether low-load BFR training can provide similar or superior benefits to traditional high-load training while being safer, time-efficient, and joint-friendly. If effective, this protocol can help clinicians and coaches implement evidence-based BFR programs to enhance endurance, reduce fatigue, and improve performance in recreational runners.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Outcome Assessor Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 35.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • Males between the ages of 20 and 35
  • Recreational runners (those who have been jogging on average three times per week for at least six months).
  • No known cardiovascular, neuromuscular, or musculoskeletal disorders.
  • No participation in BFRT or similar occlusion training protocols in the past 3 months.
  • (to eliminate the carry-over effect)
  • Willingness to comply with the 6-week training protocol and testing schedule.

Exclusion Criteria

  • Any existing lower-limb injury, chronic pain or recent surgery
  • Those who have already sustained lower limb injuries.
  • Subjects who were hypertensive (greater than 130 by 80 mm Hg).
  • Those who are taking GH, anabolic steroids.
  • Vascular health problems (deep vein thrombosis, varicose veins).

Outcomes

Primary Outcomes

Running performance (distance measured)

Time Frame: baselines, 3 weeks, 6 weeks

Muscle fatigue (Lactate Analyzer)

Time Frame: baselines, 3 weeks, 6 weeks

Leg strength

Time Frame: baselines, 3 weeks, 6 weeks

Lower limb endurance

Time Frame: baselines, 3 weeks, 6 weeks

lower limb Circumference measurement

Time Frame: baselines, 3 weeks, 6 weeks

Secondary Outcomes

  • Leg strength(Lower limb endurance)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

SAURABH SHARMA

Amity institute of physiotherapy, Amity Institute of Health Allied Science

Study Sites (1)

Loading locations...

Similar Trials